How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery—Risk stratification of papillary thyroid carcinoma in young patients

How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery—Risk stratification of papillary thyroid carcinoma in young patients—

Published:2021 Issue:8 Volume:68 Page:871-880
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Kakudo Kennichi¹,Liu Zhiyan²,Bai Yanhua³,Li Yaqiong⁴,Kitayama Naomi⁵,Satoh Shinya⁶,Nakashima Masahiro⁷,Jung Chan Kwon⁸

Affiliation:

1. Department of Pathology, Cancer Genome Center and Thyroid Disease Center, Izumi City General Hospital, Osaka, Japan

2. Department of Pathology, Shanghai Sixth People’s Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China

3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China

4. Department of Pathology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China

5. Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

6. Department of Endocrine Surgery, Yamashita Thyroid Hospital, Fukuoka, Japan

7. Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

8. Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/68/8/68_EJ21-0018/_pdf

Reference67 articles.

1. 1 Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102: 605–613.

2. 2 Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140: 317–322.

3. 3 Li M, Maso LD, Vaccarella S (2020) Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabtes Endocrinol 8: 468–470.

4. 4 Kakudo K, Wakasa T, Ohta Y, Yane K, Ito Y, et al. (2015) Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling Index: how to report high-risk thyroid carcinomas? Endocr J 62: 1–12.

5. 5 Bai Y, Kakudo K, Jung CK (2020) Updates in the pathologic classification of thyroid neoplasms: a review of the WHO classification. Endocr Metab (Seoul) 35: 696–715.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness;Medicina;2023-01-04

2. Clinically Insignificant Papillary Thyroid Carcinoma and Self-limiting Carcinoma that Do Not Harm Patients;Thyroid FNA Cytology;2023

3. Low-Risk Neoplasms in the Fifth Edition of the WHO Classification of Thyroid Tumors;Thyroid FNA Cytology;2023

4. Consideration of Patients’ Viewpoint and the Role of Pathologists in Reporting Diagnosis of Thyroid Carcinomas;Thyroid FNA Cytology;2023

5. Emerging Biomarkers in Thyroid Practice and Research;Cancers;2021-12-31